LUPIN:NSE
Lupin Ltd
₹2,205.00
arrow_downward
-0.90%(-20.00) 1D
Aug 20, 3:30:00 PM GMT+5:30 · INR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LUPIN...
Open
₹2,228.30
High
₹2,237.70
Low
₹2,201.50
Mkt. cap
1.01T
Avg. vol.
0.00
Volume
531.96K
Dividend
0.82%
Quarterly dividend
₹4.50
Ex-dividend date
Jul 17, 2026
P/E ratio
17.24
52-wk high
₹2,529.50
52-wk low
₹1,875.00
EPS
₹127.94
Shares outstanding
452.41M
No. of employees
26K
Open
₹2,228.30
High
₹2,237.70
Low
₹2,201.50
Mkt. cap
1.01T
Avg. vol.
0.00
Volume
531.96K
Dividend
0.82%
Quarterly dividend
₹4.50
Ex-dividend date
Jul 17, 2026
P/E ratio
17.24
52-wk high
₹2,529.50
52-wk low
₹1,875.00
EPS
₹127.94
Shares outstanding
452.41M
No. of employees
26K
News stories
From web sources and news partners
Pharmaceutical Executive
·
5 hours ago
M&A Roundup: IntraGel & UroGen Sign Collaboration & Investment Agreements, Lupin & Tenpoint Form Commercialization Collaboration
The Economic Times
·
2 days ago
Lupin shares in focus after USFDA nod for drug to treat excessive daytime sleepiness
Profile
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is primarily a manufacturer of generic drugs, covering therapeutic areas such as paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.The company operates in multiple international markets including the United States, Japan, Europe, and Australia.. Wikipedia
About Lupin Ltd
CEOVinita D. Gupta
Employees26K
Founded1968
HeadquartersMumbai, Maharashtra, India
SectorPharmaceutical industry
Websitelupin.com
AI content may include mistakes. Learn more